Doctor profile · Federal record

Dr. Dally Legaspi, APRN, FNP-C

Family Nurse Practitioner (CMS: Nurse Practitioner) · Nurse Practitioner · Ocala, FL

  • NPI 1942849955
  • Accepts Medicare
  • MIPS 94.0 / 100 · 2023
  • 7 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3130 Sw 32Nd Ave
Ocala, FL 344744445
(352) 732-4032
fax (352) 732-4191
Additional location
806 N Logan Ave
Danville, IL 618323716
(217) 431-4290

Credentials & registration

NPPES · NUCC
NPI registered
December 2019 — 7 yrs on file
Profile last updated
February 27, 2023
Year of graduation
2019 — 7 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State licenses (2)
Florida #APRN11006318 · Illinois #209019359

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1942849955. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
25,348
Distinct HCPCS
10
Medicare allowed
$285,519
HCPCS Description Services Patients Avg allowed
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 9,000 14 $3
Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram 8,640 13 $0
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 2,860 18 $42
J1437 Injection, ferric derisomaltose, 10 mg 1,900 19 $21
J0897 Injection, denosumab, 1 mg 1,500 16 $23
J1100 Injection, dexamethasone sodium phosphate, 1 mg 280 17 $0
99213 Established patient office or other outpatient visit, 20-29 minutes 261 176 $75
99214 Established patient office or other outpatient visit, 30-39 minutes 202 156 $106
96372 Injection of drug or substance under skin or into muscle 185 80 $12
96375 Injection of additional new drug or substance into vein 114 39 $12

In context: peer comparison

Among 70 peers in this city , average services per provider: 213. This provider delivers 119× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,556
Transactions
121
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Merck Sharp & Dohme LLC 13 $311.53
PFIZER INC. 13 $272.78
AstraZeneca Pharmaceuticals LP 10 $267.76
Celgene Corporation 15 $224.09
Novartis Pharmaceuticals Corporation 15 $222.40
Genmab U.S., Inc. 4 $165.74
Janssen Biotech, Inc. 11 $158.47
Daiichi Sankyo Inc. 10 $153.12
E.R. Squibb & Sons, L.L.C. 9 $131.39
Alexion Pharmaceuticals, Inc. 5 $112.07
JAZZ PHARMACEUTICALS INC. 3 $92.23
ABBVIE INC. 4 $88.94
Regeneron Healthcare Solutions, Inc. 3 $88.49
Eisai Inc. 3 $88.30
TAIHO ONCOLOGY, INC. 3 $87.95

By nature of payment

Food and Beverage
$3,404
Education
$152

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
515
Patients
237
Total drug cost
$46,605
Drug Type Claims Patients Total cost
Anastrozole Generic 159 73 $7,053
Tamoxifen Citrate Generic 53 21 $2,383
Prochlorperazine Maleate Generic 38 29 $1,314
Alendronate Sodium Generic 34 12 $382
Eliquis (Apixaban) Brand 32 12 $31,509
Letrozole Generic 30 14 $965
Prednisone Generic 25 15 $185
Allopurinol Generic 22 13 $236
Cephalexin Generic 20 18 $136
Hydroxyurea Generic 20 0 $961

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Dally Legaspi's medical specialty?
Dr. Dally Legaspi practices Family Nurse Practitioner in Ocala, FL.
Where does Dr. Dally Legaspi practice?
Dr. Dally Legaspi practices at 3130 Sw 32Nd Ave, Ocala, FL 344744445. Office phone: 3527324032.
What is Dr. Dally Legaspi's NPI?
Dr. Dally Legaspi's National Provider Identifier (NPI) is 1942849955, issued by NPPES.
Does Dr. Dally Legaspi accept Medicare assignment?
Yes. Dr. Dally Legaspi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dally Legaspi commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS J1568). Source: CMS Medicare Physician & Other Practitioners file.